Trial Profile
A Phase I Study of Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Patients With Refractory and/or Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Topotecan (Primary) ; Carboplatin
- Indications Solid tumours
- Focus Adverse reactions
- 03 May 2011 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
- 03 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2007 Status change from discontinued to in progress.